Dementia other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(5 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Template:Dementia}}
{{Template:Dementia}}
{{CMG}}
{{CMG}}
== Other Diagnostic Studies ==
 
* Genetic testing
== Overview ==
* Cerebrospinal fluid (CSF) analysis is suggested in some cases
Most patients do not require a full neuropsychological examination as part of an evaluation for dementia; however, testing is useful when bedside cognitive testing is equivocal. Follow-up testing or just serial observations generally provide more helpful information than a single study, particularly when results are equivocal.<ref name="pmid18714062">{{cite journal |vauthors=Holtzer R, Verghese J, Wang C, Hall CB, Lipton RB |title=Within-person across-neuropsychological test variability and incident dementia |journal=JAMA |volume=300 |issue=7 |pages=823–30 |date=August 2008 |pmid=18714062 |pmc=2736784 |doi=10.1001/jama.300.7.823 |url=}}</ref>
* [[Electroencephalogram]] ([[EEG]]) may be used to diagnose [[Creutzfeldt-Jakob disease]] or underlying metabolic/toxic disorders  
==Other Diagnostic Studies==
Different diagnostic modalities used to make in diagnosis of dementias include:
 
*Genetic testing
*Cerebrospinal fluid (CSF) analysis is suggested in some cases
*[[Electroencephalogram]] ([[EEG]]) may be used to diagnose [[Creutzfeldt-Jakob disease]] or underlying metabolic/toxic disorders
*Lumber puncture
*[[Brain biopsy]]
*Positron emission tomography (PET)<ref name="pmid12940841">{{cite journal |vauthors=Mirzaei S, Rodrigues M, Koehn H, Knoll P, Bruecke T |title=Metabolic impairment of brain metabolism in patients with Lewy body dementia |journal=Eur. J. Neurol. |volume=10 |issue=5 |pages=573–5 |date=September 2003 |pmid=12940841 |doi=10.1046/j.1468-1331.2003.00650.x |url=}}</ref> <ref name="pmid11245717">{{cite journal |vauthors=Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT |title=Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD |journal=Neurology |volume=56 |issue=5 |pages=643–9 |date=March 2001 |pmid=11245717 |doi=10.1212/wnl.56.5.643 |url=}}</ref>
*Single-photon emission computed tomography ([[SPECT]])<ref name="pmid11976799">{{cite journal |vauthors=Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT |title=A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping |journal=Eur. J. Nucl. Med. Mol. Imaging |volume=29 |issue=5 |pages=615–22 |date=May 2002 |pmid=11976799 |doi=10.1007/s00259-002-0778-5 |url=}}</ref>
*[[Venereal disease research laboratory (VDRL) test|VDRL]]
*HIV testing
 
==References==
==References==
{{reflist|2}}
{{WH}}
{{WS}}


{{reflist|2}}
[[Category:Signs and symptoms]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Psychiatry]]
[[Category:Psychiatry]]
[[Category:Primary care]]
[[Category:Needs overview]]
[[Category:Needs overview]]
{{WH}}
{{WS}}

Latest revision as of 15:50, 9 October 2020

Dementia Microchapters

Patient Information

Overview

Classification

Causes

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Most patients do not require a full neuropsychological examination as part of an evaluation for dementia; however, testing is useful when bedside cognitive testing is equivocal. Follow-up testing or just serial observations generally provide more helpful information than a single study, particularly when results are equivocal.[1]

Other Diagnostic Studies

Different diagnostic modalities used to make in diagnosis of dementias include:

References

  1. Holtzer R, Verghese J, Wang C, Hall CB, Lipton RB (August 2008). "Within-person across-neuropsychological test variability and incident dementia". JAMA. 300 (7): 823–30. doi:10.1001/jama.300.7.823. PMC 2736784. PMID 18714062.
  2. Mirzaei S, Rodrigues M, Koehn H, Knoll P, Bruecke T (September 2003). "Metabolic impairment of brain metabolism in patients with Lewy body dementia". Eur. J. Neurol. 10 (5): 573–5. doi:10.1046/j.1468-1331.2003.00650.x. PMID 12940841.
  3. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT (March 2001). "Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD". Neurology. 56 (5): 643–9. doi:10.1212/wnl.56.5.643. PMID 11245717.
  4. Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT (May 2002). "A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping". Eur. J. Nucl. Med. Mol. Imaging. 29 (5): 615–22. doi:10.1007/s00259-002-0778-5. PMID 11976799.

Template:WH Template:WS